Robin Smith - Director, Sorrento Therapeutics, Inc

As of September 3, 2021


What is Robin Smith's Net Worth?

The current estimated net worth of Sorrento Therapeutics, Inc's Director, Robin Smith, is estimated to be about $1.37M . Robin Smith owns about 60,000 units of Sorrento Therapeutics, Inc common stock. In the last 2 years at Sorrento Therapeutics, Inc, Robin Smith has sold an estimated value of $0 worth.

What is Robin Smith's Past Insider Trading?

Robin Smith's largest purchase order was 40,000 units , worth over $90.9K on March 5, 2020. In total, Robin Smith has made about 5 transactions over 2 years of their time at Sorrento Therapeutics, Inc. Robin Smith usually trades in September, August, December, June and March, with the busiest year in 2021 and 2020.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Robin Smith's' Mailing Address?

  • Mailing address is C/o Phase Iii Medical, Inc. 330 South Service Road, Suite 120 Melville NY 11747 NY

Sorrento Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Compensation
Total
Henry Ji, Ph.D. 2019 $781,400 $* $7,320,203 $12,790 $8,114,393
Henry Ji, Ph.D. 2018 $670,000 - $3,832,500 - $4,502,500
Henry Ji, Ph.D. 2017 $600,000 - $945,000 - $1,545,000
Jiong Shao 2019 $450,000 - $776,220 $6,174 $1,232,394
Jiong Shao 2018 $356,250 - $2,993,000 - $3,349,250
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/850261/000156459020042218/srne-def14a_20201016.htm

What are Sorrento Therapeutics, Inc's Past Insider Trades?

Sorrento Therapeutics, Inc's most recent insider trade came on June 14, 2022 by Henry Ji who bought 10,000 units worth $14K . In the last 12 years, insiders at Sorrento Therapeutics, Inc have sold an estimated value of $17.87M and bought an estimated value of $12.4M worth of shares. Insider trading is most common in November, with the busiest year in 2013. The most active traders at the company are Henry Ji, See Remarks,  Kim Janda, Director,  and Jaisim Shah, Director .

Sorrento Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1